(Over)correction of FMR1 deficiency with YAC transgenics: Behavioral and physical features

Human Molecular Genetics

Volumn 9, Issue 8, 2000, Pages 1145-1159

  Peier, Andrea M ^a   McIlwain, Kellie L ^a   Kenneson, Aileen ^b   Warren, Stephen T ^b   Paylor, Richard ^a   Nelson, David L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; CELL SPECIFICITY; DNA FLANKING REGION; EXPLORATORY BEHAVIOR; FEMALE; FRAGILE X SYNDROME; KNOCKOUT MOUSE; MACROORCHIDISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SPECIFICITY; TRANSGENIC MOUSE; YEAST ARTIFICIAL CHROMOSOME;

ANIMALIA; MUS MUSCULUS;

EID: 0034194228     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.8.1145     Document Type: Article

References (75)

1. Morton, J.E., Bundey, S., Webb, T.P., MacDonald, F., Rindl, P.M. and Bullock, S. (1997) Fragile X syndrome is less common than previously estimated. J. Med. Genet., 34, 1-5.
2. Turner, G., Webb, T., Wake, S. and Robinson, H. (1996) Prevalence of fragile X syndrome. Am. J. Med. Genet., 64, 196-197.
3. Rousseau, F., Rouillard, P., Morel, M.L., Khandjian, E.W. and Morgan, K. (1995) Prevalence of carriers of premutation-size alleles of the FMRI gene and implications for the population genetics of the fragile X syndrome. Am. J. Hum. Genet., 57, 1006-1018.
4. Fu, Y.H., Kuhl, D.P., Pizzuti, A., Pieretti, M., Sutcliffe, J.S., Richards, S., Verkerk, A.J., Holden, J.J. Fenwick, R.G.,Jr., Warren, S.T. et al. (1991) Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell, 67, 1047-1058.
5. Oberle, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boue, J., Bertheas, M.F. and Mandel, J.L. (1991) Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science, 252, 1097-1102.
6. Verkerk, A.J., Pieretti, M., Sutcliffe, J.S., Fu, Y.H., Kuhl, D.P., Pizzuti, A., Reiner, O., Richards, S., Victoria, M.F., Zhang, F.P. et al. (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell, 65, 905-914.
7. De Boulle, K., Verkerk, A.J., Reyniers, E., Vits, L., Hendrickx, J., Van Roy, B., Van den Bos, F., de Graaff, E., Oostra, B.A. and Willems, P.J. (1993) A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nature Genet., 3, 31-35.
8. Meijer, H., de Graaff, E., Merckx, D.M., Jongbloed, R.J., de Die-Smulders, C.E., Engelen, J.J., Fryns, J.P., Curfs, P.M. and Oostra, B.A. (1994) A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the fragile X syndrome. Hum. Mol. Genet., 3, 615-620.
9. Lugenbeel, K.A., Peier, A.M., Carson, N.L., Chudley, A.E. and Nelson, D.L. (1995) Intragenic loss of function mutations demonstrate the primary role of FMR1 in fragile X syndrome. Nature Genet., 10, 483-485.
10. Hagerman, R.J. and Cronister, A. (1996) Fragile X Syndrome: Diagnosis. Treatment and Research. 2nd Edn. Johns Hopkins University Press, Baltimore, MD.
11. Abitbol, M., Menini, C., Delezoide, A.L., Rhyner, T., Vekemans, M. and Mallet, J. (1993) Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nature Genet., 4, 147-153.
12. Devys, D., Lutz, Y., Rouyer, N., Bellocq, J.P. and Mandel, J.L. (1993) The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nature Genet., 4, 335-340.
13. Tamanini, F., Willemsen, R., van Unen, L., Bontekoe, C., Galjaard, H., Oostra, B.A. and Hoogeveen, A.T. (1997) Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis. Hum. Mol. Genet., 6, 1315-1322.
14. Ashley, C.T., Sutcliffe, J.S., Kunst, C.B., Leiner, H.A., Eichler, E.E., Nelson, D.L. and Warren, S.T. (1993) Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat. Nature Genet., 4, 244-251.
15. Hergersberg, M., Matsuo, K., Gassmann, M., Schaffner, W., Luscher, B., Rulicke, T. and Aguzzi, A. (1995) Tissue-specific expression of a FMR1/ beta-galactosidase fusion gene in transgenic mice. Hum. Mol. Genet., 4, 359-366.
16. Bachner, D., Manca, A., Steinbach, P., Wohrle, D., Just, W., Vogel, W., Hameister, H. and Poustka, A. (1993) Enhanced expression of the murine FMR1 gene during germ cell proliferation suggests a special function in both the male and the female gonad. Hum. Mol. Genet., 2, 2043-2050.
17. Khandjian, E.W., Fortin, A., Thibodeau, A., Tremblay, S., Cote, F., Devys. D., Mandel, J.L. and Rousseau, F. (1995) A heterogeneous set of FMRPs is widely distributed in mouse tissues and is modulated in cell culture. Hum. Mol. Genet., 4, 783-789.
18. Sittler, A., Devys, D., Weber, C. and Mandel, J.L. (1996) Alternative splicing of exon 14 determines nuclear or cytoplasmic localisation of fmr1 protein isoforms. Hum. Mol. Genet., 5, 95-102.
19. Siomi, H., Siomi, M.C., Nussbaum, R.L. and Dreyfuss, G. (1993) The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell, 74, 291-298.
20. Khandjian, E.W., Corbin, F., Woerly, S. and Rousseau, F. (1996) The fragile X mental retardation protein is associated with ribosomes. Nature Genet., 12, 91-93.
21. Eberhart, D.E., Malter, H.E., Feng, Y. and Warren, S.T. (1996) The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum. Mol. Genet., 5, 1083-1091.
22. Feng, Y., Gutekunst, C.A., Eberhart, D.E., Yi, H., Warren, S.T. and Hersch, S.M. (1997) Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J. Neurosci., 17, 1539-1547.
23. Bardoni, B., Sittler, A., Shen, Y. and Mandel, J.L. (1997) Analysis of domains affecting intracellular localization of the FMRP protein. Neurobiol. Dis., 4, 329-336.
24. Fridell, R.A., Bogerd, H.P. and Cullen, B.R. (1996) Nuclear export of late HIV-1 mRNAs occurs via a cellular protein export pathway. Proc. Natl Acad. Sci. USA, 93, 4421-4424.
25. Bakker, C.E. and T.D.-B.F.X. Consortium (1994) Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium. Cell, 78, 23-33.
26. Rudelli, R.D., Brown, W.T., Wisniewski, K., Jenkins, E.C., Laure-Kamionowska, M., Connell, F. and Wisniewski, H.M. (1985) Adult fragile X syndrome. Clinico-neuropathologic findings. Acta Neuropathol., 67, 289-295.
27. Hinton, V.J., Brown, W.T., Wisniewski, K. and Rudelli, R.D. (1991) Analysis of neocortex in three males with the fragile X syndrome. Am. J. Med. Genet., 41, 289-294.
28. Wisniewski, K.E., Segan, S.M., Miezejeski, C.M., Sersen, E.A. and Rudelli, R.D. (1991) The Fra (X) syndrome: neurological, electrophysiological, and neuropathological abnormalities. Am. J. Med. Genet., 38, 476-480.
29. Comery, T.A., Harris, J.B., Willems, P.J., Oostra, B.A., Irwin, S.A., Weiler, I.J. and Greenough, W.T. (1997) Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc. Natl Acad. Sci. USA, 94, 5401-5404.
30. Huxley, C. (1998) Exploring gene function: use of yeast artificial chromosome transgenesis. Methods, 14, 199-210.
31. Gaensler, K.M., Kitamura, M. and Kan, Y.W. (1993) Germ-line transmission and developmental regulation of a 150-kb yeast artificial chromosome containing the human beta-globin locus in transgenic mice. Proc. Natl Acad. Sci. USA, 90, 11381-11385.
32. Peterson, K.R., Clegg, C.H., Huxley, C., Josephson, B.M., Haugen, H.S., Furukawa, T. and Stamatoyannopoulos, G. (1993) Transgenic mice containing a 248-kb yeast artificial chromosome carrying the human beta-globin locus display proper developmental control of human globin genes. Proc. Natl Acad. Sci. USA, 90, 7593-7597.
33. Hodgson, J.G., Smith, D.J., McCutcheon, K., Koide, H.B., Nishiyama, K., Dinulos, M.B., Stevens, M.E., Bissada, N., Nasir, J., Kanazawa, I. et al. (1996) Human huntingtin derived from YAC transgenes compensates for loss of murine huntingtin by rescue of the embryonic lethal phenotype. Hum. Mol. Genet., 5, 1875-1885.
34. D'Hooge, R., Nagels, G., Franck, F., Bakker, C.E., Reyniers, E., Storm, K., Kooy, R.F., Oostra, B.A., Willems, P.J. and De Deyn, P.P. (1997) Mildly impaired water maze performance in male Fmr1 knockout mice. Neuroscience, 76, 367-376.
35. Kooy, R.F., D'Hooge, R., Reyniers, E., Bakker, C.E., Nagels, G., De Boulle, K., Storm, K., Clincke, G., De Deyn, P.P., Oostra, B.A. et al. (1996) Transgenic mouse model for the fragile X syndrome. Am. J. Med. Genet., 64, 241-245.
36. Srivastava, A.K. and Schlessinger, D. (1991) Vectors for inserting selectable markers in vector arms and human DNA inserts of yeast artificial chromosomes (YACs). Gene, 103, 53-59.
37. Brown, V., Small, K., Lakkis, L., Feng, Y., Gunter, C., Wilkinson, K.D. and Warren, S.T. (1998) Purified recombinant Fmrp exhibits selective RNA binding as an intrinsic property of the fragile X mental retardation protein. J. Biol. Chem., 273, 15521-15527.
38. Hiremath, L.S., Webb, N.R. and Rhoads, R.E. (1985) Immunological detection of the messenger RNA cap-binding protein. J. Biol. Chem., 260, 7843-7849.
39. Duncan, R. and Hershey, J.W. (1983) Identification and quantitation of levels of protein synthesis initiation factors in crude HeLa cell lysates by two-dimensional polyacrylamide gel electrophoresis. J. Biol. Chem., 258, 7228-7235.
40. Duncan, R., Milburn, S.C. and Hershey, J.W. (1987) Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggest a role in translational control. Heat shock effects on eIF-4F. J. Biol. Chem., 262, 380-388.
41. Wei, C.L., MacMillan, S.E. and Hershey, J.W. (1995) Protein synthesis initiation factor eIF-1A is a moderately abundant RNA-binding protein. J. Biol. Chem., 270, 5764-5771.
42. Paylor, R., Nguyen, M., Crawley, J.N., Patrick, J., Beaudet, A. and Orr-Urtreger, A. (1998) Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. Learn. Mem., 5, 302-316.
43. Dawson, G.R., Flint, J. and Wilkinson, L.S. (1999) Testing the genetics of behavior in mice. Science, 285, 2068-2070.
44. Crawley, J.N. (1989) Animal models of anxiety. Curr. Opin. Psychiatry, 2, 773-776.
45. Crawley, J. and Goodwin, F.K. (1980) Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol. Biochem. Behav., 13, 167-170.
46. Paylor, R., Hirotsune, S., Gambello, M.J., Yuva-Paylor, L., Crawley, J.N., and Wynshaw-Boris, A. (1999) Impaired learning and motor behavior in heterozygous Pafahlbl (Lis1) mutant mice [in process citation]. Learn. Mem., 6, 521-537.
47. Geyer, M.A. and Braff, D.L. (1987) Startle habitation and sensorimotor gating in schizophrenia and related animal models. Schizophr. Bull., 13, 643-668.
48. Paylor, R., Tracy, R., Wehner, J. and Rudy, J.W. (1994) DBA/2 and C57BL/6 mice differ in contextual fear but not auditory fear conditioning. Behav. Neurosci., 108, 810-817.
49. Morris, R. (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods, 11, 47-60.
50. Davis, M. (1992) The role of the amygdala in fear-potentiated startle: implications for animal models of anxiety. Trends Pharmacol. Sci., 13, 35-41.
51. Davis, M., Walker, D.L. and Lee, Y. (1997) Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex. Philos. Trans R. Soc. Lond. B Biol. Sci., 352, 1675-1687.
52. Pellow, S., Chopin, P., File, S.E. and Briley, M. (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 14, 149-167.
53. Toubas, P.L., Abla, K.A., Cao, W., Logan, L.G. and Scale, T.W. (1990) Latency to enter a mirrored chamber: a novel behavioral assay for anxiolytic agents. Pharmacol. Biochem. Behav., 35, 121-126.
54. Paradee, W., Melikian, H.E., Rasmussen, D.L., Kenneson, A., Conn, P.J. and Warren, S.T. (1999) Fragile X mouse: Strain effects of knockout phenotype and evidence suggesting deficient amygdala function. Neuroscience, 94, 185-192.
55. Paylor, R., Baskall, L. and Wehner, J.M. (1993) Behavioral dissociations between C57BL/6 and DBA/2 mice on learning and memory tasks: A hippocampal-dysfunction hypothesis. Psychobiology, 21, 11-26.
56. Lifschytz, E. and Lindsley, D.L. (1972) The role of X-chromosome inactivation during spermatogenesis (Drosophila-allocycly-chromosome evolution-male sterility-dosage compensation). Proc. Natl Acad. Sci. USA, 69, 182-186.
57. Slegtenhorst-Eegdeman, K.E., de Rooij, D.G., Verhoef-Post, M., van de Kant, H.J, Bakker, C.E., Oostra, B.A., Grootegoed, J.A. and Themmen, A.P. (1998) Macroorchidism in FMR1 knockout mice is caused by increased Sertoli cell proliferation during testicular development. Endocrinology, 139, 156-162.
58. Kola, I. and Hertzog, P.J. (1998) Down syndrome and mouse models. Curr. Opin. Genet. Dev. 8, 316-321.
59. Williams, C.A., Zori, R.T., Hendrickson, J., Stalker, H., Marum, T., Whidden, E. and Driscoll, D.J. (1995) Angelman syndrome. Curr. Probl. Pediatr., 25, 216-231.
60. Willard, H.F. (1996) X chromosome inactivation and X-linked mental retardation. Am. J. Med. Genet, 64, 21-26.
61. Ema, M., Ikegami, S., Hosoya, T., Mimura, J., Ohtani, H., Nakao, K., Inokuchi, K., Katsuki, M. and Fujii-Kuriyama, Y. (1999) Mild impairment of learning and memory in mice overexpressing the mSim2 gene located on chromosome 16: an animal model of Down's syndrome. Hum. Mol. Genet., 8, 1409-1415.
62. Sago, H., Carlson, E.J., Smith, D.J., Kilbridge, J., Rubin, E.M., Mobley, W.C., Epstein, C.J. and Huang, T.T. (1998) TslCje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc. Natl Acad. Sci. USA, 95, 6256-6261.
63. Jiang, Y.H., Armstrong, D., Albrecht, U., Atkins, C.M., Noebels, J.L., Eichele, G., Sweatt, J.D. and Beaudet, A.L. (1998) Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation [see comments]. Neuron, 21, 799-811.
64. Davies, N.P. and Huxley, C. (1996) YAC transfer into mammalian cells by cell fusion. Methods Mol. Biol., 54, 281-292.
65. Ceman, S., Brown, V. and Warren, S.T. (1999) Isolation of an FMRP-associated messenger ribonucleoprotein particle and identification of nucleolin and the fragile X-related proteins as components of the complex. Mol. Cell. Biol., 19, 7925-7932.
66. Feng, Y., Absher, D., Eberhart, D.E., Brown, V., Malter, H.E. and Warren, S.T. (1997) FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol. Cell, 1, 109-118.
67. Weiler, I.J., Irwin, S.A., Klintsova, A.Y., Spencer, C.M., Brazelton, A.D., Miyashiro, K., Comery, T.A., Patel, B., Eberwine, J. and Greenough, W.T. (1997) Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc. Natt Acad. Sci. USA, 94, 5395-5400.
68. Torre, E.R. and Warren, S.T. (1999) Dendritic spine maturation is delayed in cultured hippocampal neurons of the Fmr1 knockout mouse. Am. J. Hum. Genet., 65, 2670(a).
69. Smith, D.J., Zhu, Y., Zhang, J., Cheng, J.F. and Rubin, E.M. (1995) Construction of a panel of transgenic mice containing a contiguous 2-Mb set of YAC/P1 clones from human chromosome 21q22.2. Genomics, 27, 425-434.
70. Eichler, E.E., Holden, J.J., Popovich, B.W., Reiss, A.L., Snow, K., Thibodeau, S.N., Richards, C.S., Ward, P.A. and Nelson, D.L. (1994) Length of uninterrupted CGG repeats determines instability in the FMRI gene. Nature Genet., 8, 88-94.
71. Riggins, G.J., Sherman, S.L., Oostra, B.A., Sutcliffe, S.S., Feitell, D., Nelson, D.L., van Oost, B.A., Smits, A.P., Ramos, F.J., Pfendner, E. et al. (1992) Characterization of a highly polymorphic dinucleotide repeat 150 kb proximal to the fragile X site. Am. J. Med. Genet., 43, 237-243.
72. Wohrle, D., Kotzot, D., Hirst, M.C., Manca, A., Korn, B., Schmidt, A., Barbi, G., Rott, H.D., Poustka, A., Davies, K.E. et al. (1992) A microdeletion of less than 250 kb, including the proximal part of the FMR-I gene and the fragile-X site, in a male with the clinical phenotype of fragile-X syndrome. Am. J. Hum Genet., 51, 299-306.
73. Gu, Y., Lugenbeel, K.A., Vockley, J.G., Grody, W.W. and Nelson, D.L. (1994) A de novo deletion in FMR1 in a patient with developmental delay. Hum. Mol. Genet., 3, 1705-1706.
74. Kirkpatrick, L.L., McIlwain, K.A. and Nelson, D.L. (1999) Alternative splicing in the murine and human FXR1 genes. Genomics, 59, 193-202.
75. Shaffer, L.G., McCaskill, C., Han, J.Y., Choo, K.H., Cutillo, D.M., Donnenfeld, A.E., Weiss, L. and Van Dyke, D.L. (1994) Molecular characterization of de novo secondary trisomy 13. Am. J. Hum. Genet., 55, 968-974.